Eavor’s next-generation geothermal project awarded €91,6 million grant from the European Innovation Fund
Globe Newswire9-03-2023, 23:37
Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology 1-08-2023, 19:23